Clinical Trial Update: Phase Ib Study AZD1775 in Combination With Carboplatin and Paclitaxel in Adult Asian Patients With Solid Tumours [Phase 1]

View source ↗

Summary

Phase Ib study of AZD1775 with carboplatin and paclitaxel in adult Asian patients with solid tumours has completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumours

Drugs mentioned

• AZD1775 (Adavosertib)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: AstraZeneca | Conditions: Advanced Solid Tumours | Phase 1 | Status: COMPLETED | Results posted: 2019-03-25